Reversing Type 2 Diabetes: The Time for Lifestyle Medicine Has Come!-Reference-Cited by-同舟云学术

Reversing Type 2 Diabetes: The Time for Lifestyle Medicine Has Come!

Published:2020-07-03 Issue:7 Volume:12 Page:1974
ISSN:2072-6643
Container-title:Nutrients
language:en
Short-container-title:Nutrients

Author:

Lemieux Isabelle^ORCID

Abstract

The IDF (International Diabetes Federation) Diabetes Atlas Committee has recently published the global estimates of diabetes prevalence for 2019 [...]

Publisher

MDPI AG

Subject

Food Science,Nutrition and Dietetics

Link

https://www.mdpi.com/2072-6643/12/7/1974/pdf

Reference31 articles.

1. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition

2. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications

3. Weight Gain as a Risk Factor for Clinical Diabetes Mellitus in Women

4. Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement

5. Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Fenugreek in the Management of Type 2 Diabetes;International Journal of Molecular Sciences;2024-06-26

2. Age-specific differences in the association between prediabetes and cardiovascular diseases in China: A national cross-sectional study;World Journal of Diabetes;2024-02-15

3. Clinical correlates and thyroid hormones of metabolic syndrome in first-episode and drug-naïve major depressive disorder outpatients with and without hyperglycemia: a comprehensive cross-sectional study;BMC Psychiatry;2023-09-04

4. Tenofovir alafenamide significantly increased serum lipid levels compared with entecavir therapy in chronic hepatitis B virus patients;World Journal of Hepatology;2023-08-27

5. The role of regulated necrosis in inflammation and ocular surface diseases;Experimental Eye Research;2023-08